Literature DB >> 24668879

Craniofacial and dental development in Costello syndrome.

Alice F Goodwin1, Snehlata Oberoi, Maya Landan, Cyril Charles, Jessica C Massie, Cecilia Fairley, Katherine A Rauen, Ophir D Klein.   

Abstract

Costello syndrome (CS) is a RASopathy characterized by a wide range of cardiac, musculoskeletal, dermatological, and developmental abnormalities. The RASopathies are defined as a group of syndromes caused by activated Ras/mitogen-activated protein kinase (MAPK) signaling. Specifically, CS is caused by activating mutations in HRAS. Although receptor tyrosine kinase (RTK) signaling, which is upstream of Ras/MAPK, is known to play a critical role in craniofacial and dental development, the craniofacial and dental features of CS have not been systematically defined in a large group of individuals. In order to address this gap in our understanding and fully characterize the CS phenotype, we evaluated the craniofacial and dental phenotype in a large cohort (n = 41) of CS individuals. We confirmed that the craniofacial features common in CS include macrocephaly, bitemporal narrowing, convex facial profile, full cheeks, and large mouth. Additionally, CS patients have a characteristic dental phenotype that includes malocclusion with anterior open bite and posterior crossbite, enamel hypo-mineralization, delayed tooth development and eruption, gingival hyperplasia, thickening of the alveolar ridge, and high palate. Comparison of the craniofacial and dental phenotype in CS with other RASopathies, such as cardio-facio-cutaneous syndrome (CFC), provides insight into the complexities of Ras/MAPK signaling in human craniofacial and dental development.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  CS; Costello syndrome; MAPK pathway; RASopathy; Ras; craniofacial development; enamel; gingival hyperplasia; malocclusion; occlusion; receptor tyrosine kinase; signal transduction; tooth development

Mesh:

Substances:

Year:  2014        PMID: 24668879      PMCID: PMC4115793          DOI: 10.1002/ajmg.a.36475

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  21 in total

1.  Mechanisms of ectodermal organogenesis.

Authors:  Johanna Pispa; Irma Thesleff
Journal:  Dev Biol       Date:  2003-10-15       Impact factor: 3.582

2.  HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy.

Authors:  Anne L Estep; William E Tidyman; Michael A Teitell; Philip D Cotter; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2006-01-01       Impact factor: 2.802

3.  Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.

Authors:  Pablo Rodriguez-Viciana; Osamu Tetsu; William E Tidyman; Anne L Estep; Brenda A Conger; Molly Santa Cruz; Frank McCormick; Katherine A Rauen
Journal:  Science       Date:  2006-01-26       Impact factor: 47.728

Review 4.  HRAS and the Costello syndrome.

Authors:  K A Rauen
Journal:  Clin Genet       Date:  2007-02       Impact factor: 4.438

Review 5.  FGF signalling in craniofacial development and developmental disorders.

Authors:  X Nie; K Luukko; P Kettunen
Journal:  Oral Dis       Date:  2006-03       Impact factor: 3.511

6.  Sprouty genes control diastema tooth development via bidirectional antagonism of epithelial-mesenchymal FGF signaling.

Authors:  Ophir D Klein; George Minowada; Renata Peterkova; Aapo Kangas; Benjamin D Yu; Herve Lesot; Miroslav Peterka; Jukka Jernvall; Gail R Martin
Journal:  Dev Cell       Date:  2006-08       Impact factor: 12.270

Review 7.  Craniofacial and dental manifestations of Proteus syndrome: a case report.

Authors:  K B Becktor; J P Becktor; P S Karnes; E E Keller
Journal:  Cleft Palate Craniofac J       Date:  2002-03

8.  Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.

Authors:  Tetsuya Niihori; Yoko Aoki; Yoko Narumi; Giovanni Neri; Hélène Cavé; Alain Verloes; Nobuhiko Okamoto; Raoul C M Hennekam; Gabriele Gillessen-Kaesbach; Dagmar Wieczorek; Maria Ines Kavamura; Kenji Kurosawa; Hirofumi Ohashi; Louise Wilson; Delphine Heron; Dominique Bonneau; Giuseppina Corona; Tadashi Kaname; Kenji Naritomi; Clarisse Baumann; Naomichi Matsumoto; Kumi Kato; Shigeo Kure; Yoichi Matsubara
Journal:  Nat Genet       Date:  2006-02-12       Impact factor: 38.330

9.  Abnormal Ras signaling in Costello syndrome (CS) negatively regulates enamel formation.

Authors:  Alice F Goodwin; William E Tidyman; Andrew H Jheon; Amnon Sharir; Xu Zheng; Cyril Charles; James A Fagin; Martin McMahon; Thomas G H Diekwisch; Bernhard Ganss; Katherine A Rauen; Ophir D Klein
Journal:  Hum Mol Genet       Date:  2013-09-20       Impact factor: 6.150

10.  Germline mutations in HRAS proto-oncogene cause Costello syndrome.

Authors:  Yoko Aoki; Tetsuya Niihori; Hiroshi Kawame; Kenji Kurosawa; Hirofumi Ohashi; Yukichi Tanaka; Mirella Filocamo; Kumi Kato; Yoichi Suzuki; Shigeo Kure; Yoichi Matsubara
Journal:  Nat Genet       Date:  2005-09-18       Impact factor: 38.330

View more
  7 in total

1.  Costello syndrome: Clinical phenotype, genotype, and management guidelines.

Authors:  Karen W Gripp; Lindsey A Morse; Marni Axelrad; Kathryn C Chatfield; Aaron Chidekel; William Dobyns; Daniel Doyle; Bronwyn Kerr; Angela E Lin; David D Schwartz; Barbara J Sibbles; Dawn Siegel; Suma P Shankar; David A Stevenson; Mihir M Thacker; K Nicole Weaver; Sue M White; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2019-06-20       Impact factor: 2.802

Review 2.  The duality of human oncoproteins: drivers of cancer and congenital disorders.

Authors:  Pau Castel; Katherine A Rauen; Frank McCormick
Journal:  Nat Rev Cancer       Date:  2020-04-27       Impact factor: 60.716

Review 3.  Modeling craniofacial and skeletal congenital birth defects to advance therapies.

Authors:  Cynthia L Neben; Ryan R Roberts; Katrina M Dipple; Amy E Merrill; Ophir D Klein
Journal:  Hum Mol Genet       Date:  2016-06-26       Impact factor: 6.150

Review 4.  A review of craniofacial and dental findings of the RASopathies.

Authors:  H Cao; N Alrejaye; O D Klein; A F Goodwin; S Oberoi
Journal:  Orthod Craniofac Res       Date:  2017-06       Impact factor: 1.826

Review 5.  Costello syndrome with special cutaneous manifestations and HRAS G12D mutation: A case report and literature review.

Authors:  Wen Qian; Meijie Zhang; Hequn Huang; Yihe Chen; Gajin Park; Ni Zeng; Yueyue Li; Qian Lu; Dan Luo
Journal:  Mol Genet Genomic Med       Date:  2021-05-01       Impact factor: 2.183

Review 6.  The RASopathies: from pathogenetics to therapeutics.

Authors:  Katie E Hebron; Edjay Ralph Hernandez; Marielle E Yohe
Journal:  Dis Model Mech       Date:  2022-02-18       Impact factor: 5.758

Review 7.  From Bench to Bedside and Back: Improving Diagnosis and Treatment of Craniofacial Malformations Utilizing Animal Models.

Authors:  Alice F Goodwin; Rebecca Kim; Jeffrey O Bush; Ophir D Klein
Journal:  Curr Top Dev Biol       Date:  2015-10-06       Impact factor: 4.897

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.